Berkeley Lab’s Innovation and Partnerships Office executed licensing agreements this spring to move two biotechnologies from the lab to the marketplace. The Engevity Cuff, developed by Berkeley Lab researcher Jonathan Maltz, improves cardiovascular disease diagnosis by measuring endothelial health and plaque buildup. Startup Lexington Biosciences will refine and commercialize the cuff design. OpenMSI leverages Big Data resources to analyze, visualize, manage and share MSI data in real time, anywhere in the world, promising to advance disease diagnostics and therapeutics, among other biotech applications. Imabiotech licensed Open MSI intellectual property to support its own imaging platform.
